Cargando…
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon
The poor aqueous solubility of new and existing drug compounds represents a significant challenge in pharmaceutical development, with numerous strategies currently being pursued to address this issue. Amorphous solids lack the repeating array of atoms in the structure and present greater free energy...
Autores principales: | Jones, Eleanor C. L., Bimbo, Luis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150833/ https://www.ncbi.nlm.nih.gov/pubmed/32121652 http://dx.doi.org/10.3390/pharmaceutics12030214 |
Ejemplares similares
-
Towards controlling the crystallisation behaviour of fenofibrate melt: triggers of crystallisation and polymorphic transformation
por: Tipduangta, Pratchaya, et al.
Publicado: (2018) -
Two-step crystallisation in a 2D active magnetic granular system confined by a parabolic potential
por: Escobar, A., et al.
Publicado: (2023) -
Crystallisation and characterisation of muscle proteins: a mini-review
por: Govada, Lata, et al.
Publicado: (2023) -
Exploring the thermal behaviour of the solvated structures of nifedipine
por: Jones, Eleanor C. L., et al.
Publicado: (2023) -
Non-classical crystallisation pathway directly observed for a pharmaceutical crystal via liquid phase electron microscopy
por: Cookman, J., et al.
Publicado: (2020)